Science & Society illustration

Science & Society

Science & Society is an initiative at Duke dedicated to integrating and fostering innovation in research, education, and engagement at the intersection of science and society, especially in the areas of law, policy, genetics, medicine, neuroscience, engineering, and education. Our faculty, post-docs, research associates, and professional staff work together to:

  • Improve science communication and the accountability of scientists to the public
  • Embed the ethical, legal, and social implications of science in science education
  • Use evidence-based research to inform changes in law, government policy, and the behavior of individuals
  • Provide a research environment that is more intimately embedded in the community it seeks to support
  • Ensure research can deliver tangible, ethical, and beneficial contributions to society

Click here for the Science & Society web site.

MA in Bioethics & Science Policy

Biotechnology has changed the food we eat, how we communicate, the medicines we use, and so much more. Advances in the sciences and technology shape our lives and our societies, and raise myriad questions: Is it ethical to clone part of a human being? Should we use technologies that enhance or alter our brains? Will we permit the police to store DNA forever, even for those who have never committed a crime? Duke’s MA in Bioethics & Science Policy invites students to address these questions and many more.

Both Science & Society and the MA program are led by Nita Farahany, JD, Ph.D., whose work focuses on the ethical, legal, and social implications of biosciences and emerging technologies, particularly those related to law, neuroscience and behavioral genetics. Since 2010, Professor Farahany has served on President Obama’s Commission for the Study of Bioethical Issues.

Click here for more information about the MA.

The IGSP also houses the Center for Public Genomics (CpG), a Center of Excellence in Ethical, Legal, and Social Implications (ELSI) Research exploring the value of "open science" norms co-funded by the Department of Energy and the NIH.

Related News

Genome Sequencing: Who Gets to Use the Data?

“With 23andMe, the FDA said you cannot tell people what this genetic information means for their health,” Misha Angrist says. “You can tell them about their ancestry or a gene ...

Related Publications

Moving Beyond "Isolated" Gene Patents

The U.S. Supreme Court decided that not all gene patents are alike. Bob Cook-Deegan and Arti Rai ask what this means for research, innovation, business, and patients.

IGSP Interactome

Nita Farahany, PhD, JD
Nita Farahany, PhD, JD Law School
Misha Angrist, PhD
Misha Angrist, PhD Science & Society
Allen Buchanan, PhD
Allen Buchanan, PhD Philosophy
Subhashini Chandrasekharan, PhD
Subhashini Chandrasekharan, PhD Science & Society
Evan Charney, PhD
Evan Charney, PhD Sanford School of Public Policy
Robert Cook-Deegan, MD
Robert Cook-Deegan, MD Sanford School of Public Policy
Lauren Dame, JD, MPH
Lauren Dame, JD, MPH Law
Susanne B. Haga, PhD
Susanne B. Haga, PhD Sanford School of Public Policy
Alison Hill, PhD
Alison Hill, PhD Biology
Scott Huettel, PhD
Scott Huettel, PhD Psychology & Neuroscience
Sara Katsanis, MS
Sara Katsanis, MS Science & Society
Andrew Krystal, MD
Andrew Krystal, MD Psychiatry and Behavioral Sciences
Robert Mitchell, PhD
Robert Mitchell, PhD English
Arti K. Rai, JD
Arti K. Rai, JD Duke Law
Joel Rosch, PhD
Joel Rosch, PhD Center for Child and Family Policy
Alex Rosenberg, PhD
Alex Rosenberg, PhD Philosophy
Charmaine D. M. Royal, PhD
Charmaine D. M. Royal, PhD African-American Studies
Walter Sinnott-Armstrong, PhD
Walter Sinnott-Armstrong, PhD Philosophy
Priscilla Wald, PhD
Priscilla Wald, PhD English